Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1031

1.

Changes in parameters of right ventricular function with cardiac resynchronization therapy.

Sharma A, Lavie CJ, Vallakati A, Garg A, Goel S, Lazar J, Fonarow GC.

Clin Cardiol. 2017 Sep 12. doi: 10.1002/clc.22762. [Epub ahead of print]

2.

Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry.

Echouffo-Tcheugui JB, Shrader P, Thomas L, Gersh BJ, Kowey PR, Mahaffey KW, Singer DE, Hylek EM, Go AS, Peterson ED, Piccini JP, Fonarow GC.

J Am Coll Cardiol. 2017 Sep 12;70(11):1325-1335. doi: 10.1016/j.jacc.2017.07.755.

PMID:
28882229
3.

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis.

Khan MS, Fonarow GC, Khan H, Greene SJ, Anker SD, Gheorghiade M, Butler J.

ESC Heart Fail. 2017 Sep 4. doi: 10.1002/ehf2.12204. [Epub ahead of print] Review.

PMID:
28869332
4.

Regional Variation in Utilization, In-hospital Mortality, and Health-Care Resource Use of Transcatheter Aortic Valve Implantation in the United States.

Gupta T, Kalra A, Kolte D, Khera S, Villablanca PA, Goel K, Bortnick AE, Aronow WS, Panza JA, Kleiman NS, Abbott JD, Slovut DP, Taub CC, Fonarow GC, Reardon MJ, Rihal CS, Garcia MJ, Bhatt DL.

Am J Cardiol. 2017 Aug 10. pii: S0002-9149(17)31308-5. doi: 10.1016/j.amjcard.2017.07.102. [Epub ahead of print]

PMID:
28865889
5.

Maximizing Cardiovascular Event Reduction by Expanding and Intensifying the Targets.

Ziaeian B, Fonarow GC.

Circulation. 2017 Aug 29;136(9):813-816. doi: 10.1161/CIRCULATIONAHA.117.029844. No abstract available.

PMID:
28847796
6.

Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry.

Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR; ORBIT-AF Steering Committee.

Eur Heart J Qual Care Clin Outcomes. 2017 Jul 1;3(3):192-197. doi: 10.1093/ehjqcco/qcx004.

PMID:
28838088
7.

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease.

Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS.

JAMA Cardiol. 2017 Aug 23. doi: 10.1001/jamacardio.2017.2762. [Epub ahead of print]

PMID:
28832867
8.

Unexplained Variation for Hospitals' Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic Stroke.

Xian Y, Thomas L, Liang L, Federspiel JJ, Webb LE, Bushnell CD, Duncan PW, Schwamm LH, Stein J, Fonarow GC, Hoenig H, Montalvo C, George MG, Lutz BJ, Peterson ED, Bettger JP.

Stroke. 2017 Aug 22. pii: STROKEAHA.117.016904. doi: 10.1161/STROKEAHA.117.016904. [Epub ahead of print]

PMID:
28830975
9.

Biomarker-Guided vs Guideline-Directed Titration of Medical Therapy for Heart Failure.

Fonarow GC.

JAMA. 2017 Aug 22;318(8):707-708. doi: 10.1001/jama.2017.10540. No abstract available.

PMID:
28829853
10.

Regional Variation in 30-Day Ischemic Stroke Outcomes for Medicare Beneficiaries Treated in Get With The Guidelines-Stroke Hospitals.

Thompson MP, Zhao X, Bekelis K, Gottlieb DJ, Fonarow GC, Schulte PJ, Xian Y, Lytle BL, Schwamm LH, Smith EE, Reeves MJ.

Circ Cardiovasc Qual Outcomes. 2017 Aug;10(8). pii: e003604. doi: 10.1161/CIRCOUTCOMES.117.003604.

PMID:
28798017
11.
12.

Disease understanding in patients newly diagnosed with atrial fibrillation.

Kaufman BG, Kim S, Pieper K, Allen LA, Gersh BJ, Naccarelli GV, Ezekowitz MD, Fonarow GC, Mahaffey KW, Singer DE, Chan PS, Freeman JV, Ansell J, Kowey PR, Rieffel JA, Piccini J, Peterson E, O'Brien EC.

Heart. 2017 Aug 8. pii: heartjnl-2017-311800. doi: 10.1136/heartjnl-2017-311800. [Epub ahead of print]

13.

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.

Khan MS, Fonarow GC, Ahmed A, Greene SJ, Vaduganathan M, Khan H, Marti C, Gheorghiade M, Butler J.

Circ Heart Fail. 2017 Aug;10(8). pii: e003956. doi: 10.1161/CIRCHEARTFAILURE.117.003956.

PMID:
28790052
14.

Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.

Ziaeian B, Fonarow GC, Heidenreich PA.

JACC Heart Fail. 2017 Sep;5(9):632-639. doi: 10.1016/j.jchf.2017.04.008. Epub 2017 Jul 12.

PMID:
28711446
15.

Early transition to comfort measures only in acute stroke patients: Analysis from the Get With The Guidelines-Stroke registry.

Prabhakaran S, Cox M, Lytle B, Schulte PJ, Xian Y, Zahuranec D, Smith EE, Reeves M, Fonarow GC, Schwamm LH.

Neurol Clin Pract. 2017 Jun;7(3):194-204. doi: 10.1212/CPJ.0000000000000358.

PMID:
28680764
16.

National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity.

Ziaeian B, Kominski GF, Ong MK, Mays VM, Brook RH, Fonarow GC.

Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). pii: e003552. doi: 10.1161/CIRCOUTCOMES.116.003552.

PMID:
28655709
17.

Designing Future Clinical Trials in Heart Failure With Preserved Ejection Fraction: Lessons From TOPCAT.

Patel RB, Shah SJ, Fonarow GC, Butler J, Vaduganathan M.

Curr Heart Fail Rep. 2017 Aug;14(4):217-222. doi: 10.1007/s11897-017-0336-x. Review.

PMID:
28647918
18.

Seasonal and circadian variations of acute myocardial infarction: Findings from the Get With The Guidelines-Coronary Artery Disease (GWTG-CAD) program.

Nagarajan V, Fonarow GC, Ju C, Pencina M, Laskey WK, Maddox TM, Hernandez A, Bhatt DL.

Am Heart J. 2017 Jul;189:85-93. doi: 10.1016/j.ahj.2017.04.002. Epub 2017 Apr 12.

PMID:
28625385
19.

Utilization of cardiac resynchronization therapy in eligible patients hospitalized for heart failure and its association with patient outcomes.

Randolph TC, Hellkamp AS, Zeitler EP, Fonarow GC, Hernandez AF, Thomas KL, Peterson ED, Yancy CW, Al-Khatib SM.

Am Heart J. 2017 Jul;189:48-58. doi: 10.1016/j.ahj.2017.04.001. Epub 2017 Apr 6.

PMID:
28625381
20.

Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).

Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O'Brien EC, Singer DE, Peterson ED, Piccini JP; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients.

Am Heart J. 2017 Jul;189:40-47. doi: 10.1016/j.ahj.2017.03.024. Epub 2017 Apr 4.

Supplemental Content

Loading ...
Support Center